Related Experiment Video
Updated: Mar 12, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Glucocorticoid-Induced Leucine Zipper Protein Controls Macropinocytosis in Dendritic Cells
Joseph Calmette1, Matthieu Bertrand1, Mathias Vétillard1
1UMR996-Inflammation, Chimiokines et Immunopathologie, INSERM, Université Paris-Sud, Université Paris-Saclay, Clamart 92140, France.
Insights
Glucocorticoid-induced leucine zipper protein (GILZ) inhibits macropinocytosis in dendritic cells (DCs), impacting antigen cross-presentation. This regulation fine-tunes immune responses by controlling Ag uptake mechanisms.
Area of Science:
- Immunology
- Cell Biology
Background:
- Dendritic cells (DCs) are crucial for T cell activation through antigen (Ag) sampling.
- DCs utilize macropinocytosis, receptor-mediated endocytosis, and phagocytosis for Ag uptake.
Purpose of the Study:
- To investigate the regulatory mechanisms of Ag uptake by DCs.
- To determine the role of GILZ in controlling Ag sampling by DCs.
Main Methods:
- In vitro and in vivo studies using LPS-stimulated DCs.
- Analysis of Ag uptake pathways, including macropinocytosis and phagocytosis.
- Assessment of GILZ expression and its effect on p38 MAPK phosphorylation.
Main Results:
- GILZ selectively inhibits macropinocytosis, not phagocytosis, in immature and activated DCs.
- GILZ-mediated inhibition of Ag uptake is specific to the CD8α+ DC subset in vivo.
- GILZ limits p38 MAPK phosphorylation in activated DCs, suggesting a mechanism for macropinocytosis control.
- Modulation of Ag uptake by GILZ affects CD8 T cell cross-presentation but not CD4 T cell presentation.
Conclusions:
- GILZ acts as an endogenous inhibitor of macropinocytosis in DCs.
- GILZ fine-tunes Ag cross-presentation efficiency by regulating DC Ag uptake.
Abstract:
Ag sampling is a key process in dendritic cell (DC) biology. DCs use constitutive macropinocytosis, receptor-mediated endocytosis, and phagocytosis to capture exogenous Ags for presentation to T cells. We investigated the mechanisms that regulate Ag uptake by DCs in the steady-state and after a short-term LPS exposure in vitro and in vivo. We show that the glucocorticoid-induced leucine zipper protein (GILZ), already known to regulate effector versus regulatory T cell activation by DCs, selectively limits macropinocytosis, but not receptor-mediated phagocytosis, in immature and recently activated DCs. In vivo, the GILZ-mediated inhibition of Ag uptake is restricted to the CD8α+ DC subset, which expresses the highest GILZ level among splenic DC subsets. In recently activated DCs, we further establish that GILZ limits p38 MAPK phosphorylation, providing a possible mechanism for GILZ-mediated macropinocytosis control. Finally, our results demonstrate that the modulation of Ag uptake by GILZ does not result in altered Ag presentation to CD4 T cells but impacts the efficiency of cross-presentation to CD8 T cells. Altogether, our results identify GILZ as an endogenous inhibitor of macropinocytosis in DCs, the action of which contributes to the fine-tuning of Ag cross-presentation.

